Abstract:Background Hepatocellular carcinoma (HCC) is one of the most leading causes of cancer death worldwide. The 5-year survival rate of HCC patients remains low due to the lack of early-stage symptoms. Human complement factor H-related protein 4 (CFHR4) is a critical gene that belongs to the factor H family of plasma glycoproteins, which has not been linked to HCC development. The correlations between CFHR4 and prognosis and tumor-infiltrating lymphocytes in HCC are yet unknown. The present study demonstrated the involvement of CFHR4 in HCC via data mining approaches. Results A total of 18 upregulated and 67 down-regulated differentially expressed genes (DEGs) were identified. Importantly, CFHR4, which was screened from DEGs, was shown to express at a lower level in HCC tumor tissue than normal tissues. Western blotting (WB), immunohistochemical (IHC) and quantitative reverse transcription PCR (qRT-PCR) experiments of clinical samples further validated CFHR4 was aberrantly expressed in HCC patients; Data from TCGA showed that CFHR4 was inversely correlated with a cancer family history, histological grade, tumor node metastasis (TNM) stage, and serum AFP level of HCC patients; Univariate and multivariate analyses revealed that low expression of CFHR4 was an independent predictive marker in patients with HCC; Kaplan-Meier analysis showed that the lower expression of CFHR4 was significantly associated with the progression of HCC and poor prognosis rates. Furthermore, TIMER analysis indicated that CFHR4 expression levels had correlations with infiltrating levels of immune cells in HCC. Conclusion CFHR4 expression was low in HCC and was significantly related to the poor prognosis of HCC and the level of immune infiltration. CFHR4 played important roles in regulating the initiation and progression of HCC and could be a potential biomarker for the diagnosis and prognosis of HCC. Methods The expression of CFHR4 was analyzed by GEO and TCGA-LIHC database and verified by WB and IHC assay. The biological function of CFHR4 was performed by GO and KEGG enrichment analysis, and the genomic alteration of CFHR4 was investigated by cBioPortal database.The correlation between CFHR4 expression and clinical relevance was evaluated through Cox proportional hazards model, and the correlation between CFHR4 expression and tumor immune infiltrates were studied by TIMER database.

Silencing HSF4 Can Inhibit the Proliferation of HCC Cells

SRSF10 Facilitates HCC Growth and Metastasis by Suppressing CD8+T Cell Infiltration and Targeting SRSF10 Enhances Anti-Pd-l1 Therapy

PCGF2 and PCGF4 Oppositely Drive Stem-like Properties in Hepatocellular Carcinoma

PCGF2 and PCGF4 Opposite Drive Stem-like Properties in Hepatocellular Carcinoma

The Clinical and Prognostic Implications of Pluripotent Stem Cell Gene Expression in Hepatocellular Carcinoma

Decreased STAT4 Indicates Poor Prognosis and Enhanced Cell Proliferation in Hepatocellular Carcinoma.

[OCT4 Expression in Hepatocellular Carcinoma and Its Clinical Significance].

Clinicopathological Significance of Stat4 in Hepatocellular Carcinoma and Its Effect on Cell Growth and Apoptosis

HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression

HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.

Mir-3682-3p Directly Targets FOXO3 and Stimulates Tumor Stemness in Hepatocellular Carcinoma Via a Positive Feedback Loop Involving FOXO3/PI3K/AKT/c-Myc

Hepatocyte Nuclear Factor 4 Alpha Suppresses the Development of Hepatocellular Carcinoma

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma

YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1

The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway

Identification of CFHR4 Associated with Poor Prognosis of Hepatocellular Carcinoma

The Stromal-Tumor Amplifying STC1-Notch1 Feedforward Signal Promotes the Stemness of Hepatocellular Carcinoma

Coexpression of Gene Oct4 and Nanog Initiates Stem Cell Characteristics in Hepatocellular Carcinoma and Promotes Epithelial-Mesenchymal Transition Through Activation of Stat3/Snail Signaling

OCT 4 expression in hepatocellular carcinoma and its clinical significance

SOX13 regulates cancer stem-like properties and tumorigenicity in hepatocellular carcinoma cells

Hypoxia induces stemness properties in hepatocellular carcinoma cells